Abstract
Background and purposeRecombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) was not inferior to alteplase for ischaemic stroke within 4.5 hours. Our study aimed to investigate the efficacy and safety of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have